TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Results of Operations and Financial Condition

TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

On March 12, 2018, Tonix Pharmaceuticals Holding Corp. announced its operating results for the fiscal year ended December 31, 2017. A copy of the press release that discusses this matter is filed as Exhibit 99.01 to, and incorporated by reference in, this report. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section.

Item 9.01 Financial Statements and Exhibits.

* Furnished herewith.


Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 s109312_ex99-1.htm EXHIBIT 99.01   Exhibit 99.01   Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Programs Update   Interim Analysis for Phase 3 HONOR study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) in Military-Related PTSD Expected in Third Quarter of 2018; Topline Results Expected in Fourth Quarter of 2018   NEW YORK,…
To view the full exhibit click here

An ad to help with our costs